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Abstract
RNA-dependent RNA polymerases (RdRps) play a key role in the life cycle of RNA viruses
and impact their immunobiology. The arenavirus lymphocytic choriomeningitis virus (LCMV)
strain Clone 13 provides a benchmark model for studying chronic infection. A major genetic
determinant for its ability to persist maps to a single amino acid exchange in the viral L pro-
tein, which exhibits RdRp activity, yet its functional consequences remain elusive. To
unravel the L protein interactions with the host proteome, we engineered infectious L pro-
tein-tagged LCMV virions by reverse genetics. A subsequent mass-spectrometric analysis
of L protein pulldowns from infected human cells revealed a comprehensive network of inter-
acting host proteins. The obtained LCMV L protein interactome was bioinformatically inte-
grated with known host protein interactors of RdRps from other RNA viruses, emphasizing
interconnected modules of human proteins. Functional characterization of selected interac-
tors highlighted proviral (DDX3X) as well as antiviral (NKRF, TRIM21) host factors. To cor-
roborate these findings, we infected Trim21-/- mice with LCMV and found impaired virus
control in chronic infection. These results provide insights into the complex interactions of
the arenavirus LCMV and other viral RdRps with the host proteome and contribute to a bet-
ter molecular understanding of how chronic viruses interact with their host.
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Author summary
RNA-dependent RNA-polymerases (RdRps) play a key role in the life cycle of RNA
viruses. They interact with cellular proteins during replication and transcription processes
and impact the immunobiology of viral infections. This study characterized the host pro-
tein interactome of the RdRp-containing L protein of the prototypic arenavirus lympho-
cytic choriomeningitis virus (LCMV). Several L protein interactors with proviral and
antiviral effects were identified in vitro, and mice lacking the identified L protein interac-
tor TRIM21 exhibited impaired control of chronic LCMV infection. Integration of the L
protein interactomes with known RdRp interactomes from other RNA viruses highlighted
common and virus-specific strategies to interact with the host proteome, which may indi-
cate novel avenues for antiviral interventions.
Introduction
RNA viruses hijack and utilize host factors at all steps of their life cycle. The viral RNA-depen-
dent RNA polymerase (RdRp) is a key enzyme responsible for transcription and replication of
viral genomes. Three-dimensional complete protein structures are available for RdRps from
different RNA viruses and feature a similar “right handed” structure containing six conserved
motifs [1–3]. The high similarity of RdRps between different viruses suggests that they might
interact with similar host factors in the viral life cycle. Global host–virus protein interaction
networks provided invaluable insights into infection biology [4–8], and similar approaches
hold promise for an in-depth understanding of how viral RdRps interact with the host.
Lymphocytic choriomeningitis virus (LCMV) is a (-) RNA virus of the Arenaviridae and
represents a well-established model system that led to seminal findings in immunology and
host-pathogen research [9–12]. Particularly, it serves as a benchmark model of chronic viral
infections [9, 13] whereby the strain Clone 13 (Cl13) causes immunosuppression and persists
in mice for several months [14, 15]. The genetically closely related LCMV strain Armstrong
(ARM) leads to acute infection, which is efficiently cleared from the blood of infected mice
within a week [14, 15]. A single amino acid exchange at the position 1079 of the L protein
(K1079Q) was found to be required for the ability of Cl13 to establish persistence with addi-
tional contribution of the mutation F260L in the viral glycoprotein [14–16]. The L gene
encodes the largest open reading frame (250 kDa) in the LCMV genome, which together with
the viral nucleoprotein (NP) forms the ribonucleoprotein complex (RNP) required for viral
transcription and replication [17, 18]. The L protein contains several domains of which the
NL1 domain serves as a type II endonuclease and domain III possesses RdRp activity [19, 20].
Yet, a better molecular understanding of the L protein and its role in the viral biology is ham-
pered by lack of complete protein structure and unknown host protein interactors.
In this study we set out to determine the host interactome of the LCMV Cl13 L protein to
gain insights into the interactions of the LCMV replication complex with host factors and to
investigate the molecular environment that modulates viral immunobiology. We developed
infectious LCMV virions with a protein tag fused to the L protein, enabling us to identify inter-
acting host proteins by immunoprecipitation followed by mass spectrometry. Functional char-
acterization of selected interaction partners in vitro revealed the impact of several interactors
on LCMV replication. This was corroborated in mice lacking one of these interactors–
TRIM21, which exhibited impaired control of chronic LCMV infection. Finally, we integrated
previously reported interactomes from other viruses by a global network analysis and
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identified common and unique highly interconnected cellular protein functional modules tar-
geted by different viral RdRps.
Results
Generation and characterization of LCMV strains expressing a tagged L
protein
To elucidate the host protein interactome of the L protein of LCMV, we developed a strategy
of endogenous protein tagging that enabled us to analyze the host cell interaction partners in
the context of the natural infectious life cycle. Arenaviruses have a compact genome and even
minor modifications can severely affect their viability. We, thus, selected four different affinity
purification tags with a short size of 8 to 14 amino acid residues (HA, Strep II, FLAG and V5)
and introduced the tags either on the N- or C- terminus of the L ORF by insertional cDNA
mutagenesis (S1 Table). Reverse genetic rescue of the corresponding viruses revealed that all
viruses bearing an N terminally tagged L protein were efficiently generated on a Cl13 LCMV
backbone while none of the C terminally tagged L protein constructs resulted in infectious
virions (Fig 1A). This demonstrated that it was feasible to generate L protein tagged LCMV
variants with retained infectivity in cell culture. Based on the viral titers recovered, we contin-
ued to work with a LCMV Cl13 virus whose L protein was N terminally fused with a HA tag
(Cl13L-HA). To control for the expression of the tagged L protein, we prepared lysates from
cells infected with Cl13L-HA and detected the L protein at the expected size by anti-HA anti-
body (S1A Fig). To assess the effect of the introduced tag on viral propagation, we compared
the growth kinetics of Cl13L-HA to an untagged Cl13 virus upon infection of HEK293T cells.
This experiment revealed exponential growth of Cl13L-HA albeit with slight attenuation com-
pared to the untagged Cl13 virus (Fig 1B).
To assess the fitness of the LCMV variant with tagged L protein in vivo, we infected mice
with Cl13L-HA or the corresponding untagged Cl13 virus and assessed viral loads in blood (Fig
1C), spleen and liver (Fig 1D). The virus encoding the HA-tagged L protein showed a similar
kinetics of viremia compared to the untagged virus, although peak titers were lower when
mice were infected with Cl13L-HA virus. Quantification of virus-specific CD8
+ T cell responses
showed no significant differences between mice infected with either Cl13L-HA or untagged
Cl13 (Fig 1E). To assess the stability of the HA tag in the LCMV genome, we sequenced virus
from the spleen lysates of mice which had been infected with either Cl13L-HA or untagged Cl13
50 days previously. These results confirmed the presence of the HA tag and did not provide
any evidence for acquired mutations in the corresponding region at this late time point (S1B
Fig).
Together, these data indicated that Cl13L-HA has similar immunobiological characteristics
as the respective untagged Cl13 strain. These novel tools enabled us to proceed with immuno-
precipitation of the L protein in the context of a natural viral infection.
Identification of the LCMV L protein interactome
For the identification of the LCMV L protein interactome, we relied on a well-established cell
culture system [21]. HEK293T FlpIn cells infected with Cl13L-HA were used for mass spectrom-
etry analyses. In addition, we infected HA-GFP overexpressing as well as wild type HEK293T
FlpIn cells with untagged Cl13 virus which served as negative controls for the interactome
analysis. Subsequently, we performed an one-step anti-HA immunoprecipitation from
infected cell lysates (S1C Fig), and analyzed interaction partners of the LCMV L protein by
one-dimensional gel-free liquid chromatography tandem mass spectrometry (LC–MS/MS). In
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total we identified 555 proteins in the L protein pulldowns. Upon stringent filtration against
the background of our control samples (Materials and Methods), we obtained 231 interactors
for our bait (Fig 2, S2 Table). Our bioinformatic analysis, which was based on global gene set
enrichment and functional classification, revealed that the major components of the LCMV L
protein interactome are RNA biology-associated proteins (e.g. splicing, ribonucleoproteins,
ribosomal and RNA-binding proteins) and proteins related to translation and transcription
(Fig 2A and 2B). Importantly, the LCMV nucleoprotein (NP), a known interactor of the L
protein [17], was detected in all L protein pulldowns (2 biological replicates and 2 technical
replicates each) but not in our control samples infected with untagged Cl13 virus, serving as a
valuable internal control (Fig 2B, S1C Fig). In addition to the identified global clusters
depicted in Fig 2A, we found a number of interactors with reported roles in signal transduc-
tion and innate immunity (Fig 2B). These included DEAD-box helicase 3 (DDX3X), insulin-
like growth factor 2 (IGF2BP1), NF-kB repressing factor (NKRF) and Tripartite Motif Con-
taining 21 (TRIM21). To confirm selected host protein interactions for the L protein, we used
available antibodies specific to the endogenous interaction partners DDX3X, polyadenylate-
binding protein 1 (PABPC1) and TRIM21 and performed western blots on anti-HA
Fig 1. Generation and characterization of LCMV strains expressing a tagged L protein. (A) Viral titer of
N- and C-terminal L protein-tagged Cl13 LCMV and WT Cl13 LCMV measured by focus forming assay at 72
hours post infection after reverse genetic rescue on BHK21 cells. (B) HEK293T cells were infected at a MOI of
0.01 with either Cl13L-HA or with untagged Cl13. Supernatant was harvested and viral loads were measured at
the indicated time points by focus forming assay. (C and D) C57BL/6J mice were infected with 2x106 FFU of
the indicated viruses. Viral titers were determined in (C) blood at indicated time points and in (D) organs
20 days post infection. (E) C57BL/6J mice were infected with 2x106 FFU of the indicated viruses and the
percentage of GP33-specific-tetramer+ CD8+ T cells was quantified in the spleen at 8 days post infection.
Each symbol and bar represents the mean ± SEM of three to five mice. Statistical significance was calculated
by Two-way ANOVA (B-C) or unpaired t-test (D-E). Significant p values were indicated as follows: ns—non
significant, * p0.05,: ** p0.01.
https://doi.org/10.1371/journal.ppat.1006758.g001
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immunoprecipitates of Cl13L-HA-infected HEK293T cell lysates (S1D Fig). The L protein of
the acute LCMV strain ARM differs in the single amino acid exchange K1079L and plays a key
role in viral immunobiology [14–16]. We, thus, generated also an LCMV variant expressing
Fig 2. Identification of L protein interactome. (A) GO enrichment analyses for the L protein interactome based on the molecular functions (light grey) and
biological processes (dark grey) of interactors followed by visualization with ReviGO. (B) Overview of L protein interactomes classified based on the protein
functions and visualized in Cytoscape. The data is based on the mass-spectrometry derived list of proteins identified in L protein pulldowns after filtration
using Top3 quantitation and SAINTexpress software as detailed in Materials and Methods.
https://doi.org/10.1371/journal.ppat.1006758.g002
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the HA-tagged L protein of ARM to perform co-immunoprecipitation experiments. These
revealed that pulldown of the ARM L protein enriched for DDX3X, PABPC1 and TRIM21 as
well, indicating that the interactions are not affected by the mutation K1079L (S1D Fig). To
provide additional evidence for direct binding of these host proteins to the L protein in the
absence of viral RNA or other viral proteins, we transiently transfected cells with a plasmid
encoding the HA-tagged L protein of Cl13. In line with our previous findings, HA-specific
immunoprecipitation confirmed DDX3X, PABPC1 and TRIM21 as L protein interactors (S1E
Fig). We also performed a reciprocal co-immunoprecipitation experiment by transfecting
HEK293T cells with plasmids encoding HA-tagged L protein and/or V5-tagged TRIM21 (S1F
Fig), corroborating the interaction between the viral L protein and TRIM21.
Together, our experiments with endogenously-tagged infectious LCMV characterized the
host protein interactome of the LCMV L protein.
Viral RNA-dependent RNA-polymerases target the host proteome by
common and virus-specific strategies
To better understand the global landscape of interactions between viral replication machiner-
ies and the host, we integrated the LCMV L protein interactome obtained in this study with
publicly available interactome datasets on other RNA viruses (S3 Table) [22], resulting in a
comprehensive network of all hitherto known interactomes of viral RdRps (Fig 3A). We then
mapped this host-RdRp network onto the global human interactome consisting of 141,296
experimentally verified physical interactions between 13,460 proteins [23], thus allowing us to
locate all human proteins targeted by various RdRps. Proteins associated with the same disease
have been found to aggregate in the same local neighborhood of the human interactome [23].
Fig 3. Viral RNA-dependent RNA-polymerases target host proteome by common and virus-specific
strategies. (A) Integrated interactome of viral RdRp targets. Host proteins interacting with viral RdRps are
highlighted in blue, the rest of the human proteome—in grey. (B) Largest connected component (LCC)
analyses for global RdRps and LCMV only datasets. (C) Functional protein modules targeted by RdRps
based on the community detection method. (D) Heat map representing virus-specific targeting of protein
functional modules.
https://doi.org/10.1371/journal.ppat.1006758.g003
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To test whether proteins targeted by RNA viruses display a similar tendency we analyzed the
size of the largest connected component (LCC) [24], i.e. the number of directly connected pro-
teins (see Methods and Fig 3A). Out of 797 host proteins targeted by various RdRps, 663 pro-
teins are directly connected to each other by protein-protein interactions, suggesting that indeed
viruses affect a specific neighborhood of the human interactome. The obtained LCC values were
significantly higher than the random expectation both for global RdRps (p-value = 1.47e-36)
and for LCMV Cl13 L protein only (p value = 9.77e-84) datasets (Fig 3B), indicating that viral
RdRps specifically target highly interconnected host protein interactome modules.
To further elucidate the biological function of the targeted interactome neighborhood we
performed a gene ontology (GO) enrichment analyses and clustered the targets based on their
functional similarity using a network-based community detection method [25]. We identified
9 basic functional protein modules in the human proteome that are targeted by various viral
RdRps (Fig 3C–3D). While most of them are associated with RNA biology-related processes
such as RNA biosynthesis, RNA metabolic processes and ribonucleoprotein complex assem-
bly, we also identified other cellular processes including cytoskeleton reorganization and signal
transduction. Interestingly, certain protein modules are commonly targeted by all viruses (e.g.
ribonucleoprotein complex assembly) whereas other modules seem to be targeted in a virus-
specific manner (Fig 3D). These analyses pinpointed that viral RdRps target the host proteome
by common and virus-specific strategies.
Functional screening for L protein interactors involved in LCMV infection
In order to elucidate a potential functional role of the identified host factors in LCMV infec-
tion, we selected the five proteins DDX3X, FLII, IGF2BP1, NKRF and TRIM21 from the total
list of interactors. TRIM21 and DDX3X were among the proteins that are targeted by the poly-
merase complexes of several viruses [8, 21], which suggested that these host factors may play
an important role in the replication of RNA viruses. The other host proteins were selected
based on their known immune functions or their role in the life cycle of other viruses. We
designed CRISPR-Cas9 assays for the selected candidates and created two independent cell
pools by individual single guide RNA per gene. These targeted cell pools and non-target con-
trol cells were generated in HeLa S3 cells and pools of early passage 1 or 2 were used. This
human cell line supports LCMV replication and mounts an antiviral innate immune response.
Specific gene editing was confirmed by T7EI cleavage assay (S2A Fig) and TIDE approach
(S2B Fig) for the targeted cells. Further, we confirmed the decreased protein expression of
DDX3X and TRIM21 in the respective targeted cells by western blot (S2C Fig). We also
attempted to generate cells targeting the validated L interactor PABPC1, but were unsuccessful,
possibly because PABPC1 is an essential gene [26].
The obtained targeted cells were subsequently infected with Cl13 WT and viral propagation
was measured by focus forming assay (FFA) (Fig 4A). These experiments revealed that Cl13
replicated to higher titers in TRIM21-targeted and NKRF-targeted cells. Conversely, we found
reduced viral loads in DDX3X-targeted cells, which is in line with its proviral effect in HCV
infection [27]. Other targeted cells did not reveal consistent differences in viral loads, which
could reflect functional redundancies or cell type-specific properties. We also determined the
effect of LCMV infection on the expression levels of TRIM21 in infected HEK293T cells and
found, that it is not significantly changed upon infection (S3 Fig).
To further validate the findings of our functional screen, we performed reconstitution
experiments with TRIM21. TRIM21-targeted cells were transfected with either a plasmid
expressing TRIM21 or with an empty vector (EV) control plasmid and subsequently infected
with Cl13 WT. Importantly, reconstitution with TRIM21 reversed the phenotype previously
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observed in TRIM21-targeted cells and led to reduced viral titers (Fig 4B). Similar antiviral
effects of TRIM21 were observed upon infection with ARM WT (S4A Fig).
Finally, we infected Trim21-/- and WT mice with Cl13 WT to assess viral propagation in
vivo [28]. Interestingly, Trim21-/- and WT mice showed comparable levels of viremia in the
early stage of infection but approximately two weeks after infection Trim21-/- mice exhibited
impaired control of Cl13 in the blood compared to WT mice (Fig 4C, p-value <0.0001). Simi-
larly, we found higher viral loads in spleen, liver and kidney of infected Trim21-/- mice com-
pared to WT mice (Fig 4D). We also infected Trim21-/- and WT mice with the acute strain
ARM but were unable to detect differences in viral loads in blood and other organs (S4B and
S4C Fig). This was in line with comparable viremia kinetics of Cl13 in Trim21-/- and WT mice
during the early phase of infection.
Fig 4. Functional screening for L protein interactors involved in LCMV life cycle. (A) Two independently generated
HeLa S3 CRISPR-Cas9 targeted cell pools per gene of interest for 5 genes were infected in triplicate wells with LCMV Cl13
WT at a MOI of 0.01 and viral loads were measured at 36 hours post infection by focus forming assay. The obtained data were
normalized to the non-target control and log2 transformed. (B) Two HeLa S3 CRISPR-Cas9 TRIM21-targeted cell pools were
reconstituted either with TRIM21-expressing plasmid or with non-target control and 36 hour post transfection were infected in
triplicate wells with LCMV Cl13 WT at a MOI of 0.01. Viral loads were measured at 36 hours post infection by focus forming
assay. The obtained data were normalized to the non-target control and log2 transformed. (C-D) C57BL/6 and Trim21-/- mice
were infected with 2x106 FFU of the indicated viruses. Viral titers were determined in (C) blood at indicated time points and in
(D) organs at 21 days post infection. The data shown in (C) is representative of two similar experiments. Each symbol and bar
represents the mean ± SEM of three to five mice. Statistical significance was calculated by unpaired t-test (A, B, D) or by Two-
way ANOVA (C). Significant p values were indicated as follows: ns—non significant, * p0.05, ** p0.01, *** p0.001,
**** p0.0001.
https://doi.org/10.1371/journal.ppat.1006758.g004
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In summary, these experiments provided novel insights into the impact of identified L pro-
tein interactors on the life cycle of LCMV and uncovered a non-redundant antiviral role of
TRIM21 in the control of chronic LCMV infection.
Discussion
This study gives novel insights into how the replication machinery of LCMV interacts with the
host on a protein-protein level by the use of reverse genetically engineered endogenously
tagged viruses. Similar to recent approaches for endogenous tagging of viral proteins [29–31],
this avoids potential artifacts generated by conventional ectopic overexpression of tagged viral
proteins due to non-physiological protein abundance and/or localization and may be applica-
ble to the study of other viral protein interactomes. Moreover, it enables the proteomic charac-
terization of viral RdRps and other viral proteins with cellular partners not only in cell lines
but also in more complex systems such as primary cells and tissues ex vivo. We acknowledge
that affinity purification mass-spectrometry approaches may also yield interactors which are
not directly binding to the protein-of-interest but rather to complex partners. In the case of
the L protein this may include interactions with other components of the arenaviral ribonu-
cleoprotein complex or the viral Z protein [32, 33].
Arenaviruses have compact genomes and any minor modification may severely affect infec-
tivity. Interestingly, N-terminally L-tagged LCMV constructs resulted in infectious virions,
whereas tags fused to the C terminus of the L protein prevented viral reverse genetic rescue
(Fig 1A). This may reflect impaired protein structure-function of the L protein or possibly
indicate reduced fitness due to noncoding structural effects on the viral RNA genome [34].
Our proteomic analyses demonstrate that the LCMV L protein targets multiple cellular
pathways such as RNA biology-associated modules (e.g. RNA metabolic processes and ribonu-
cleoprotein complex assembly), cytoskeleton reorganization, protein localization and transla-
tion. Interestingly, the L protein also binds to numerous host proteins associated with signal
transduction and innate immune signaling. This is of interest due to the known intricate and
multi-faceted relation of LCMV with the antiviral type I interferon system [35, 36].
By combining our proteomic results with loss-of-function experiments we implicated sev-
eral interactors in the course of LCMV infection. As examples, the E3 ligase TRIM21 and the
RNA helicase DDX3X were identified as interactors of the LCMV L protein and loss of either
protein had an effect on viral propagation. TRIM21 is known to regulate the type I interferon
response via ubiquitination of multiple interferon regulatory factors (IRFs) and acts as an
intracellular Fc receptor [37, 38], whereas DDX3X is involved in innate immune signaling cas-
cades [39, 40]. Of note, both TRIM21 and DDX3X are targeted by the polymerase complexes
of influenza virus and HCV [8, 21]. These two proteins provide an example of host factors
located at the interface of several viral RdRp interactomes. Bioinformatic analyses of integrated
host-viral interactomes can highlight such “hot spots” in the human proteome for further
investigations. Moreover, DDX3X was recently also described as interactor of LCMV NP [41],
indicating that individual host factors may bind to several viral proteins.
Based on our mass spectrometric analysis and the loss-of-function experiments in vitro, we
infected Trim21-/- mice with LCMV strain Cl13 and found impaired virus control in the late
phase of infection (Fig 3C and 3D). These results revealed a novel role for TRIM21 in the rep-
lication of LCMV both in vitro and in vivo. Of note, LCMV is an enveloped arenavirus whereas
the antibody-mediated antiviral effects of TRIM21 have been predominantly linked to non-
enveloped viruses such as adenoviruses [42], caliciviruses [38] and picornaviruses [43]. Further
investigations will be required to dissect the TRIM21-dependent mechanisms for the effective
control of chronic LCMV infection.
Characterization of the LCMV L protein interactome
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006758 December 20, 2017 9 / 20
Our proteomic results provide a data-rich resource for the study of arenaviruses in general.
Further, the LCMV L protein interactome may bring novel impetus to unravel the functional
implications of the viral K1079Q mutation and the associated immunobiological differences
between different strains of LCMV and their abilities to persist in the mouse. Finally, our
integration of the LCMV L protein interactome with publicly available data of other RdRps
emphasizes the impact of mass spectrometry-based proteomics on virological research [44],
and provides a global overview of the host factors targeted by viral RNA polymerases. Of note,
these available datasets were derived from overexpressed viral RdRps while the interactome
data of this study was obtained in the context of endogenously tagged replicating viruses and
may thus also contain proteins binding to the polymerase complex. Yet, the high interconnec-
tivity within the cluster of viral targets suggests that RdRps target functionally important pro-
tein modules. This could be associated with the conserved structure and similar functional
host-dependent requirement of viral RdRps. Further, our network analyses emphasize the fact
that viral RdRps from different taxonomy groups target functional host protein modules in
common and virus-specific ways. This may highlight RdRp-host protein interactions that are
required for the majority of RNA viruses as well as reveal unique features of distinct virus spe-
cies. This expanded view on the interaction of viral replication machineries with their host
proteomes may contribute to the development of novel antiviral therapeutic avenues.
Materials and methods
Animal experiments
C57BL/6J mice were originally obtained from The Jackson Laboratory. Trim21-/- mice were
generated by gene disruption via insertion of EGFP into exons 3–5, as described [28]. Mice
were subsequently rederived by transferring embryos from the original knockout C57BL/6
strain into pathogen-free recipient C57BL/6 females. Mouse experiments were performed with
sex- and age-matched animals under specific pathogen-free conditions.
Cells
All cell lines were maintained in Dulbecco’s Modified Eagle Medium (Gibco) supplemented
with 10% FCS (Invitrogen) and Penicillin-Streptomycin-Glutamine (Thermo Fisher Scientific,
10378016). HEK293 Flp-In TREx cells (Invitrogen) with doxycycline-dependent transgene
expression were used to generate the cell line for Strep-HA-GFP overexpression according to
the manufacture protocol. This cell line was treated for 48 h with doxycycline (1μg/mL) to
induce overexpression of the tagged protein.
Viruses and infections
L protein-tagged LCMV was generated using a reverse genetic system approach [45]. A de-
tailed description for the generation of the N-terminal HA-tagged L protein Cl13 virus
(Cl13L-HA) is provided below. The sequence encoding the HA tag (TATCCGTATGATGTGC
CGGATTATGCG) followed by the sequence encoding a short linker GGS (GGTGGTTCT)
was used to design primers for an insertional mutagenesis approach. Additionally, a single
nucleotide exchange (non-coding mutation) in the second codon of L ORF (A to G) was intro-
duced to distinguish viruses that may have lost the HA tag from wild type viruses. All primer
sequences for this reverse genetic approach are described in S1 Table. pl-L-Cl13(-) plasmids
were employed for insertional mutagenesis by PCR with Phusion High-Fidelity DNA Poly-
merase (Thermo Scientific, F530S). The obtained plasmid was further used to generate HA-
tagged L1079K virus using insertional mutagenesis. These plasmids encoding the L-tagged
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segment were used to rescue corresponding viruses according to the standard reverse genetics
protocol [45]. LCMV titers were determined by NP-specific focus forming assay (FFA) as
described previously using Vero cells (ATCC-CCL-81) [46].
Reverse genetically rescued WT (untagged) viruses were used throughout all experiments
with the exception of Fig 4C and 4D and S4B and S4C Fig. For the latter experiments with WT
and Trim21-/- mice we used passaged WT ARM and Cl13 virus stocks whose origins are
described in [15].
For mass spectrometry (MS) analyses HEK293 FlpIn TREx cells (Invitrogen, R78007) were
infected with Cl13L-HA, negative control cells Strep-HA-GFP expressing HEK293 Flp-In TREx
and empty HEK293 FlpIn TREx cells were infected with untagged Cl13 at a multiplicity of
infection (MOI) of 0.01, washed and harvested with ice-cold phosphate-buffered saline (PBS)
after 36 hours post infection.
Mice were infected intravenously with 2x106 focus forming units (FFU) of the correspond-
ing virus stock. To confirm the presence of the HA tag at 50 days post infection, total cellular
RNA was extracted from the spleen of mice infected with either Cl13L-HA or untagged Cl13
using QIAzol lysis reagent (QIAGEN, 79306) according to the standard protocol to confirm
the presence of the genetic tag. cDNA was obtained with random hexamers by Superscript II
RT PCR and used as an input for amplification with LCMV-specific primers (5‘gtgctgtgaaagct-
taccagcctatc‘3 and 5‘tatccgtatgatgtgccggattatg‘3) by Phusion High-Fidelity DNA Polymerase
(Thermo Fisher Scientific, F530S). This PCR product was analyzed by agarose (0.8%) gel elec-
trophoresis, the specific band was extracted from the gel with QIAquick Gel Extraction Kit
(QIAGEN, 28706) and analyzed by Sanger sequencing. Furthermore, the presence of the HA-
tagged L protein in infected HEK293T (ATCC- CRL-3216) cells was confirmed by western
blot analyses with anti-HA antibody.
Affinity purification mass spectrometry
Ten subconfluent 15-cm dishes of HEK293 FlpIn TREx cells were infected with Cl13L-HA at a
MOI of 0.01. Additionally, ten sub-confluent 15 cm dishes of HEK293 FlpIn TREx cells (no
bait control) or Strep-HA-GFP expressing HEK293 TREx Flp-In (GFP control) were infected
with untagged Cl13 LCMV at a MOI of 0.01. Expression of Strep-HA-tagged GFP in HEK293
TREx Flp-In cell line was induced with doxycycline (1 μg/mL) 24 hours before infection. Cells
were harvested 36 hours post infection and lysed for 30 min on ice in the IP buffer (HEPES 50
mM, pH 8.0; NaCl 150 mM, EDTA 5 mM, NP-40 0.5%, NaF 50 mM, Na3VO4 1 mM, PMSF 1
mM, protease inhibitors (P8849, Sigma)) and cleared by centrifugation. Affinity purification
was performed with anti-HA Clone 7 agarose beads (A2095, Sigma) on Biospin column (732–
6008, BioRad) using 50mg of total protein lysate. The flow-through was removed by gravity
flow and anti-HA agarose beads were washed 6 times with washing buffer (HEPES 50 mM, pH
8.0; NaCl 150 mM, EDTA 5 mM), the protein complexes were eluted with 100 mM formic
acid, neutralized with triethylammonium bicarbonate (TEAB) and digested with trypsin as
described previously [47]. The input was normalized based on western blot signal and samples
were analyzed by Liquid Chromatography Mass Spectrometry (LC–MS/MS) on a linear trap
quadrupole (LTQ) Orbitrap Velos mass spectrometer (ThermoFisher Scientific) coupled to an
Agilent 1200 HPLC nanoflow system (Agilent Biotechnologies). Details of the instrument con-
figuration and methodology are described elsewhere [48].
Co-immunoprecipitation
HEK293T cells were either infected with either Cl13L-HA or untagged Cl13 or transfected
either with L-HA encoding plasmid or empty vector control with Effectene Transfection
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reagent (QIAGEN, 301425) in 6 well plates. 36 hours post infection or transfection cells were
harvested, lysed for 30 min on ice in the IP buffer, and then the supernatant was cleared by
centrifugation. Co-immunoprecipitation of HA-tagged L protein and PABPC1 and DDX3X
was performed using anti-HA agarose beads, Clone 7 (A2095, Sigma). Total cell lysate was
incubated with anti-HA agarose overnight at 4˚C. Beads were washed 6 times with IP buffer,
proteins were eluted with 4% SDS Laemmli sample buffer at 95˚C for 10 min and analyzed by
western blot.
For reverse co-immunoprecipitation experiments HEK293T cells were transfected with
L-HA and/or TRIM21-V5 encoding plasmids with Effectene Transfection reagent (QIAGEN,
301425) in 6 well plates. TRIM21 cDNA was synthesized using the following primers: 5‘cac-
catggcttcagcagc‘3 and 5‘atagtcagtggatccttgtgatcca‘3 and subcloned with pENTR/D-TOPO
cloning kit into a plasmid backbone originating from the pTRACER-V5 plasmid (Invitrogen)
according to the manufacturer’s protocol (Thermo Fisher Scientific, 450218). L Cl13 LCMV
ORF was obtained from the plasmid described previously [45] using the following primers:
5‘caccgccatggatgaaatcatctcagaattgagag‘3 and 5‘gtcgatgtcctcggccacc‘3 subcloned by Gateway
cloning (Thermo Fisher Scientific) into a plasmid pTO-SII-HA according to the manufactur-
er’s protocol (Thermo Fisher Scientific, 450218).
36 hours post transfection cells were harvested, lysed for 30 min on ice in the IP buffer, and
then the supernatant was cleared by centrifugation. Co-immunoprecipitation of HA-tagged L
protein and V5-tagged TRIM21 was performed using anti-V5 agarose affinity gel, Clone V5-
10 (A7345, Sigma). Total cell lysate was incubated with anti-V5 agarose affinity gel overnight
at 4˚C. Beads were washed 2 times with IP buffer, proteins were eluted with 4% SDS Laemmli
sample buffer at 95˚C for 10 min and analyzed by western blot.
Western blot
Protein concentration of cell lysates was determined with Pierce Coomassie (Bradford) Protein
Assay kit (Thermo Fisher Scientific, 23200). Proteins were analyzed by SDS-Page (Thermo
Fisher Scientific, EA0375BOX) using Westran Clear signal PVDF membranes (Sigma Aldrich,
0485289) and the following antibodies: anti-HA.11 epitope tag antibody (Covance, MMS-
101P), anti-DDX3X (Bethyl Laboratories, A300-474A), anti-PABPC1 (Cell Signaling, 4992),
anti-TRIM21 (New England BioLabs, 92043) and anti-V5 Clone 5C5 (gift from M. Busslinger).
The protein size was determined with a Spectra Multicolor High Range Protein Ladder
(Thermo Fisher Scientific, 26625). Signal was detected with Pierce ECL Western blotting sub-
strate (Thermo Fisher Scientific, 32209), or Amersham ECL select Western blotting detection
reagent (GE Healthcare Life Sciences, RPN2235). Visualization was performed with the chemi-
luminescent gel documentation system MF-chemi 3.2 Pro (DNR Bio-Imaging Systems)
respectively with the Bio-Rad ChemiDoc XRS Gel Documentation system (Bio-Rad
Laboratories).
CRISPR-Cas9 engineering of targeted cells and functional screen
CRISPR-Cas9 single guide RNAs (sgRNAs) for selected target genes were designed using the
CRISPR Design Tool [49], sgRNA Designer [50] and E-CRISPR v4.2 [51] online tools based
on the target genome sequences obtained from Ensembl genome browser or merged Ensembl/
Havana transcripts. Complementary oligo sgRNAs (S4 Table) were cloned into BsmBI restric-
tion site of LentiCRISPRv2 [52] (Addgene ID 49535) that was used for lentivirus particle pro-
duction. To validate the genome editing in the targeted cells, we performed T7EI assays. PCR
products were denatured, then temperature was reduced to 25˚C. Hybridized PCR products
were digested with T7 endonuclease 1 (NEB) for 20 min at 37˚C in NEBuffer 2 (NEB, USA)
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and analyzed by agarose gel electrophoresis (2%). ImageJ 2.0 software was used to quantify the
band intensities. PCR products were analyzed by Sanger sequencing and insertion or deletion
(Indel) rates were assessed by the TIDE approach [53] using DNA of non-target control cells
as a reference control. The non-target control cells were transfected with the empty plasmid,
that could not lead to genome editing.
CRISPR-Cas9 engineered HeLa S3 cells (ATCC CLL-2.2) were infected with 0.01 of MOI of
LCMV Cl13 WT and supernatant was harvested at 36 hours post infection followed by viral load
analyses by FFA. All values were normalized to the non-target control and Log2 transformed.
Reconstitution of TRIM21-targeted cells
CRISPR-Cas9 TRIM21-targeted HeLa S3 cells were transfected with either TRIM21-encoding
plasmid or with mock control (empty vector—EV) with Effectene Transfection reagent (QIA-
GEN, 301425). 36 hours after transfection cells were infected with either wild type LCMV
strain ARM or Cl13 at a MOI of 0.01. Supernatants were harvested 36 hours after infection
and viral titers were quantified by focus forming assay. Obtained values were normalized to
the non-target control transfected with EV plasmid and Log2 transformed.
Real-time PCR
Total RNA was extracted using QIAzol lysis reagent (QIAGEN, 79306) and reverse-tran-
scribed with First Strand cDNA synthesis kit (Thermo Fisher Scientific, K1622) according
standard protocol. Gene expression by real-time PCR was analyzed using Taqman Fast Uni-
versal Master Mix (Thermo Fisher Scientific, 4352042) and Taqman Gene Expression assays
for Trim21 (Thermo Fisher Scientific, Hs00989229_g1) and for LCMV NP as described previ-
ously [54]. Gene expression data was normalized to the housekeeping gene HPRT1 (Thermo
Fisher Scientific, Hs99999909_m1).
Proteomic analysis
For protein identification the RAW MS data files were converted into Mascot generic format (.
mgf) using Proteowizard software v2.1.2708 [55] and searched against the human SwissProt
protein database (v. 2013.01) using the two search engines, Mascot (v2.3.02, MatrixScience,
London, UK) [56] and Phenyx (v2.6, GeneBio, Geneva, Switzerland) [57]. The search parame-
ters were set with carbamidomethyl cysteine and oxidized methionine as fixed and variable
modifications, respectively. One missed tryptic cleavage site was allowed. The Mascot and Phe-
nyx identifications were combined and filtered using the previously described procedure [21]
at a<1% protein false discovery rate (FDR).
Known MS contaminants such as trypsin and keratin were discarded from the results and
further filtering of proteins specifically binding to LCMV L protein was achieved by compar-
ing L protein pulldowns with the negative controls (GFP and no HA-tagged bait pulldowns)
using Top3 quantitation [58] calculated with Skyline v3.1 [59] and SAINTexpress AP-MS fil-
tering software [60]. Based on Top3 quantitation and an average of SAINT probabilities
(AvgP) >0.95, all potential interactors with>120 fold increase in abundance in L pulldowns
were considered to be high-confidence interactors. The visualization of the obtained networks
was performed in Cytoscape v.3.4.0 [61].
Gene ontology and pathway enrichment analysis
The obtained datasets for the L protein LCMV interactome were integrated with publicly avail-
able data on host-virus interactions for other viral RdRps [22] (S3 Table). Functional gene
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annotations were obtained from the Gene Ontology (GO) database [62]. Gene set enrichment
analyses were performed using Fisher’s exact test with all approved protein coding genes from
the HUGO Gene Nomenclature Committee (HGNC) [63] as background set. The resulting p-
values were corrected for multiple hypotheses testing according to the Bonferroni procedure
using a cut-off of p-value<0.05. For the visualization of the resulting GO terms we used
ReviGO [64].
Functional protein modules clustering
In order to identify groups of proteins with similar function we used the following network-
based approach: First, we quantified the functional similarity of all protein pairs from the over-
lap of their respective GO annotations using the Tanimoto coefficient: T ¼ caþb  c, where “c”
gives the number of shared annotations and “a” and “b” the number of annotations of the two
respective proteins. Next, we connected all protein pairs whose functional similarity exceeded
a threshold of T 0.1, resulting in a network of 797 human proteins, 5 viral RdRps and 1033
links. We finally used a community detection algorithm from network theory [65] to identify
groups of highly interconnected proteins, i.e. proteins with a high degree of functional coher-
ence. Each community was manually assigned a functional module name based on the most
prevalent GO-terms (S5 Table). The visualization of the network was performed in Cytoscape
v.3.4.0 [61].
Network analysis
The human host proteome we used was manually curated in [23] and contains 13,460 pro-
teins connected by 141,296 physical interactions. To quantify the extent to which a set of
viral targets is localized within a certain neighborhood of the host proteome, we analyzed
their largest connected component (LCC), i.e., the highest number of viral targets that are
directly connected to one another [23]. To test the statistical significance of a measured
LCC size, we compared it to the control distribution obtained from 100,000 random simula-
tions in which gene sets of the same size were chosen completely at random from the
network.
Statistical analyses and data visualization
Two-tailed Student’s t-tests were used for comparisons between two groups, one-way ANOVA
with Bonferroni correction were used for comparisons between multiple groups. The values
shown in the line and bar graphs indicate the mean +/- standard error of the mean. Significant
p-values are indicated as follows:  p0.05,  p0.01,  p0.001,  p0.0001. Statistical
analyses and graph preparation were performed in GraphPad Prism (version 6.0b).
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Supporting information
S1 Fig. Functional validation of Cl13L-HA virus and HA-immunoprecipitation. (A)
HEK293T cells were infected at a MOI of 3 with either Cl13L-HA or with untagged Cl13. Cells
were harvested and lysed at 36 hours post infection for western blot analyses with anti-HA
antibodies. (B) C57BL/6J mice were infected with 2x106 FFU either Cl13L-HA or untagged
Cl13 and spleen samples were analyzed 50 days post infection by Sanger sequencing. (C) Frac-
tions from one-step purification of Cl13L-HA protein were collected during the mass spectrom-
etry sample preparation and analyzed by western blot with antibodies specific to HA and NP
LCMV. NP, as a known L interactor, was used as a positive control to confirm the successful
immunoprecipitation of L-HA. Percentage indicates the amount of each fraction collected
during AP-MS pulldown preparation loaded on the gel. (D) HEK293T cells were infected with
MOI 3 either with Cl13L-HA containing either L1079K or L1079Q, or untagged virus. Cells
were harvested and lysed 36 hours post infection and co-immunoprecipitation was performed
with anti-HA followed by western blot analyses with antibodies specific to the endogenous
proteins DDX3X, PABPC1 and TRIM21 as well as HA. IP–immunoprecipitation. (E)
HEK293T cells were transfected with plasmid encoding HA-tagged L protein or empty vector
control. Cells were harvested and lysed 36 hours post transfection and co-immunoprecipita-
tion was performed with anti-HA followed by western blot analyses with antibodies specific to
the endogenous proteins DDX3X, PABPC1 and TRIM21. (F) HEK293T cells were transfected
with plasmid encoding HA-tagged L protein and/or V5-tagged TRIM21. Cells were harvested
and lysed 36 hours post transfection and co-immunoprecipitation was performed with anti-
V5 followed by western blot analyses with antibodies specific to the HA and V5.  marks a
non-specific protein band.
(TIF)
S2 Fig. Confirmation of the genome editing for CRISPR-Cas9 targeted cells. Confirmation
of the genome editing for CRISPR-Cas9 targeted cells using (A) T7EI cleavage assay followed
by the band intensity quantification with ImageJ software and (B) Sanger sequencing followed
by tracking of indels by decomposition (TIDE) quantification. For TIDE analyses primers
were designed covering the respected targeted region using Ensembl genome browser or
merged Ensembl/Havana transcripts to PCR-amplify the selected region. To evaluate indel fre-
quencies we used non-target control treated sample (transfected with an empty plasmid) as a
reference control. Bars represent indel frequencies for each cell line. (C) TRIM21 and DDX3X
CRISPR-Cas9 targeted cells were lysed and analyzed by western blot with antibodies specific
to the endogenous TRIM21 or DDX3X and actin.
(TIF)
S3 Fig. TRIM21 expression in HEK293T cells infected with Cl13 LCMV. HEK293T cells
were infected with LCMV Cl13 WT at a MOI of 3 and harvested at the indicated time points.
The gene expression for NP of LCMV and TRIM21 was measured by RT-PCR. The arbitrary
units were calculated using HPRT1 as a housekeeping gene, then fold change for each gene
was calculated using 0 hpi as a reference point for TRIM21 and 2 hpi for NP LCMV.
(TIF)
S4 Fig. Analyses of the L protein of LCMV strain ARM in vitro and in vivo. (A) Two inde-
pendently generated HeLa S3 CRISPR-Cas9 targeted cell pools per gene of interest for 5 genes
were infected in triplicate wells with LCMV ARM WT at a MOI of 0.01 and viral loads were
measured at 36 hours post infection by focus forming assay. The obtained data were normal-
ized to the non-target control and log2 transformed. (B-C) C57BL/6 and Trim21-/- mice were
infected with 2x106 FFU of the LCMV ARM WT. Viral titers were determined in (B) blood at
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indicated time points and in (C) organs at 21 days post infection. Each symbol and bar repre-
sents the mean ± SEM of three to five mice. Statistical significance was calculated by unpaired
t-test (B) or by two-way ANOVA (C). Significant p values were indicated as follows: ns—non
significant,  p0.05,  p0.01,  p0.001,  p0.0001.
(TIF)
S1 Table. Primers used for reverse genetic engineering of L protein-tagged LCMV.
(XLSX)
S2 Table. Mass spectrometry data.
(XLSX)
S3 Table. Host protein interactomes of viral RdRps from public databases.
(XLSX)
S4 Table. sgRNA oligonucleotide sequences.
(XLSX)
S5 Table. Protein functional modules targeted by L protein and other RdRps.
(XLSX)
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